Minova Life Science

Minova life sciences - Pharmaceutical company

Ropidocin Ointment

COMPOSITION РMupirocin IP 2.0% w/w 

  • ¬†Monotherapy with mupirocin 2% should be considered as a primary treatment alternative for pitted keratolysis.
  • Competitively inhibits bacterial isoleucyl transfer-RNA synthetase & inhibits bacterial protein synthesis.
  • It is used either alone or with skin antiseptics as a part of a comprehensive mesa decolonization strategy.
  • A unique antimicrobial agent because of its structure and mechanism of action. It exerts its antimicrobial activity by reversibly inhibiting isoleucyl transfer-RNA.
  • Is a tropical antibiotic largely used to eradicate staphylococcal nasal carriage

Explore other products

Scroll to Top